{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-24-000082","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.951610+00:00","generated_at":"2026-05-30T08:16:50.346461+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"CEO Joseph Woody retires; CFO Michael Greiner named interim CEO; Warren Machan interim CFO","bullets":["Joseph Woody retired as CEO and board member effective Oct 28, 2024; will consult through Apr 30, 2025 at $84,618/month.","Michael Greiner (SVP/CFO/CTO) appointed interim CEO; receives $600k salary, $83k/month stipend, and $1M RSU grant.","Warren Machan (former SVP Business Strategy) appointed interim CFO; compensation not yet determined.","Board will conduct a search for permanent CEO; Greiner is leading candidate but will evaluate other candidates.","Company reported Q3 2024 financial results via press release on Oct 30; specific figures not included in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-24-000082","json":"https://secwatch.observer/filing/0001606498-24-000082.json","markdown":"https://secwatch.observer/filing/0001606498-24-000082.md","text":"https://secwatch.observer/filing/0001606498-24-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/avns-20241028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:16:50.346461+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19ea5d313c","claim":"Michael C. Greiner was appointed as Interim Chief Executive Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"the Company appointed Michael C. Greiner to serve as Interim Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"f9a1db72a2","claim":"Joseph F. Woody retired as Chief Executive Officer at AVANOS MEDICAL, INC..","evidence_excerpt":"On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649824000082/0001606498-24-000082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}